S. Charalambous

D. Collier, A. Vassall, S. Charalambous, 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Comparing the performance of QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube among highly TB exposed gold miners in South Africa

T. Hawn, S. Charalambous, A. Grant, 2021, Gates Open Research.

Comparing the performance of QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube among highly TB exposed gold miners in South Africa

T. Hawn, S. Charalambous, A. Grant, 2021, Gates Open Research.

Effective Interpersonal Health Communication for Linkage to Care After HIV Diagnosis in South Africa

S. Charalambous, C. Hoffmann, T. Mabuto, 2016, Journal of acquired immune deficiency syndromes.

Willingness to participate in trials and to be vaccinated with new tuberculosis vaccines in HIV-infected adults.

S. Charalambous, G. Churchyard, V. Chihota, 2013, Public health action.

Neutrophils Contribute to Severity of Tuberculosis Pathology and Recovery From Lung Damage Pre- and Posttreatment

S. Charalambous, A. Rachow, S. Donkor, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Undiagnosed Tuberculosis Among HIV Clinic Attendees: Association With Antiretroviral Therapy and Implications for Intensified Case Finding, Isoniazid Preventive Therapy, and Infection Control

R. Chaisson, V. Mngomezulu, S. Charalambous, 2012, Journal of acquired immune deficiency syndromes.

Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding.

S. Charalambous, A. Grant, G. Churchyard, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Pooling sputum from multiple individuals for Xpert® MTB/RIF testing: a strategy for screening high-risk populations.

S. Charalambous, G. Churchyard, C. Hoffmann, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

An evaluation of 'Ribolola': a household tuberculosis contact tracing programme in North West Province, South Africa.

S. Charalambous, A. Grant, G. Churchyard, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

HIV infection and chronic chest disease as risk factors for bacterial pneumonia: a case–control study

S. Charalambous, G. Churchyard, K. Fielding, 2003, AIDS.

Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis

R. Shorten, A. Crook, A. Diacon, 2017, BMC Medicine.

S. Charalambous, Nishila Moodley, A. Saimen, 2020, BMC Public Health.

“It's Not Like Taking Chocolates”: Factors Influencing the Feasibility and Sustainability of Universal Test and Treat in Correctional Health Systems in Zambia and South Africa

S. Charalambous, K. Fielding, C. Hoffmann, 2019, Global Health: Science and Practice.

What causes symptoms suggestive of tuberculosis in HIV-positive people with negative initial investigations?

M. Nicol, S. Charalambous, A. Grant, 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Diagnostic Accuracy of Lateral Flow Urine LAM Assay for TB Screening of Adults with Advanced Immunosuppression Attending Routine HIV Care in South Africa

M. Nicol, S. Charalambous, A. Grant, 2016, PloS one.

Incidence of HIV-Associated Tuberculosis among Individuals Taking Combination Antiretroviral Therapy: A Systematic Review and Meta-Analysis

S. Charalambous, G. Churchyard, D. Rosillon, 2014, PloS one.

Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme

S. Charalambous, A. Grant, G. Churchyard, 2010, AIDS.

Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa.

G J Churchyard, R J Hayes, R. Hayes, 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

The Diagnostic Accuracy of Urine Lipoarabinomannan Test for Tuberculosis Screening in a South African Correctional Facility

S. Charalambous, A. Grant, G. Churchyard, 2015, PloS one.

Diagnostic Accuracy of a Urine Lipoarabinomannan Enzyme-Linked Immunosorbent Assay for Screening Ambulatory HIV-Infected Persons for Tuberculosis

R. Chaisson, S. Dorman, V. Mngomezulu, 2011, Journal of acquired immune deficiency syndromes.

High Tuberculosis Prevalence in a South African Prison: The Need for Routine Tuberculosis Screening

S. Charalambous, A. Grant, G. Churchyard, 2014, PloS one.

Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: A cohort study

R. Wood, S. Charalambous, A. Grant, 2008, BMC infectious diseases.

Risk Factors for Hospitalization or Death Among Adults With Advanced HIV at Enrollment for Care in South Africa: A Secondary Analysis of the TB Fast Track Trial

S. Charalambous, K. Fielding, C. Hoffmann, 2022, Open forum infectious diseases.

Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa. PloS

S. Charalambous, A. Grant, G. Churchyard, 2019 .

Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa

S. Charalambous, A. Grant, G. Churchyard, 2016, PloS one.

Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa

R. Chaisson, S. Charalambous, A. Grant, 2010, AIDS.

Why have trials of isoniazid preventive therapy among people with HIV infection not demonstrated an effect on mortality?: Did close examination of the trees obscure our view of the wood?

R. Chaisson, S. Charalambous, A. Grant, 2010, AIDS.

Performance of GeneXpert MTB/RIF for Diagnosing Tuberculosis Among Symptomatic Household Contacts of Index Patients in South Africa

M. Reichler, James J. Lewis, S. Charalambous, 2021, Open forum infectious diseases.

Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trial

S. Dorman, A. Vassall, S. Charalambous, 2015, Trials.

Changing Predictors of Mortality Over Time From cART Start: Implications for Care

Richard D Moore, R. Chaisson, S. Charalambous, 2011, Journal of acquired immune deficiency syndromes.

A cluster randomised trial to evaluate the effect of optimising TB/HIV integration on patient level outcomes: the "merge" trial protocol.

A. Vassall, S. Charalambous, A. Grant, 2014, Contemporary clinical trials.

Tuberculosis in prisons: an unintended sentence?

S. Charalambous, K. Velen, 2021, The Lancet. Public health.

TB Fast Track: a study to evaluate the effect of a point-of-care TB test-and-treat algorithm on early mortality in people with HIV accessing ART, a trial with randomisation at clinic level

S. Dorman, A. Vassall, S. Charalambous, 2019 .

Measuring mortality due to HIV-associated tuberculosis among adults in South Africa: Comparing verbal autopsy, minimally-invasive autopsy, and research data

D. Chandramohan, K. Kahn, S. Charalambous, 2017, PloS one.

A novel HIV treatment model using private practitioners in South Africa

S. Charalambous, A. Grant, G. Churchyard, 2012, Sexually Transmitted Infections.

Protein binding of rifampicin is not saturated when using high-dose rifampicin

Carlijn H. C. Litjens, A. Diacon, M. Hoelscher, 2018, The Journal of antimicrobial chemotherapy.

Effect of Xpert MTB/RIF testing introduction and favorable outcome predictors for tuberculosis treatment among HIV infected adults in rural southern Mozambique. A retrospective cohort study

S. Charalambous, T. Moon, J. Ramos, 2020, PloS one.

An economic evaluation of an intervention to increase demand for medical male circumcision among men aged 25–49 years in South Africa

S. Charalambous, D. Mudzengi, C. Chetty-Makkan, 2021, BMC Health Services Research.

Performance of verbal autopsy methods in estimating HIV-associated mortality among adults in South Africa

D. Chandramohan, K. Kahn, S. Charalambous, 2018, BMJ Global Health.

Chronic hepatitis B increases mortality and complexity among HIV‐coinfected patients in South Africa: a cohort study

S. Charalambous, G. Churchyard, C. Innes, 2016, HIV medicine.

Comparison of Tenofovir, Zidovudine, or Stavudine as Part of First-Line Antiretroviral Therapy in a Resource-Limited-Setting: A Cohort Study

James J. Lewis, S. Charalambous, A. Grant, 2013, PloS one.

Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus pneumoniae carriage isolates among HIV-infected mineworkers in South Africa.

R. Chaisson, S. Charalambous, A. Grant, 2008, The Journal of infection.

Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trial

C. Orrell, S. Charalambous, R. Mukora, 2021, Trials.

Universal test-and-treat in Zambian and South African correctional facilities: a multisite prospective cohort study.

M. Muyoyeta, S. Charalambous, R. Mukora, 2020, The lancet. HIV.

“Knock Knock”: a qualitative study exploring the experience of household contacts on home visits and their attitude towards people living with TB in South Africa

S. Charalambous, C. Chetty-Makkan, K. Velen, 2020, BMC Public Health.

Comparing QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube for diagnosis of latent tuberculosis infection among highly TB exposed gold miners in South Africa

T. Hawn, S. Charalambous, A. Grant, 2022, Gates open research.

Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa

P. Mee, S. Charalambous, A. Grant, 2008, AIDS.

Establishing a workplace antiretroviral therapy programme in South Africa

R. Chaisson, R. Wood, S. Charalambous, 2007, AIDS care.

Feasibility and acceptability of a specialist clinical service for HIV-infected mineworkers in South Africa

S. Charalambous, A. D. Grant, J. H. Day, 2004, AIDS care.

Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B

R. Chaisson, C. Thio, S. Charalambous, 2007, AIDS.

Use of traditional medicine by HIV-infected individuals in South Africa in the era of antiretroviral therapy

S. Charalambous, A. Grant, G. Churchyard, 2007, Psychology, health & medicine.

Understanding healthcare and population mobility in southern Africa: The case of South Africa.

J. Hanefeld, S. Charalambous, Richard D. Smith, 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

"That is why I stopped the ART": Patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme

Salome Charalambous, S. Charalambous, A. Grant, 2008, BMC public health.

Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study

S. Charalambous, A. Grant, G. Churchyard, 2010, BMC public health.

High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.

P. Butcher, M. Hatherill, S. Charalambous, 2014, The New England journal of medicine.

A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa

A. Vassall, M. Nicol, S. Charalambous, 2017, PloS one.

Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners.

R. Hayes, C. Dye, S. Charalambous, 2004, American journal of respiratory and critical care medicine.

Cytomegalovirus Viremia as a Risk Factor for Mortality Prior to Antiretroviral Therapy among HIV-Infected Gold Miners in South Africa

A. Wald, L. Corey, S. Charalambous, 2011, PloS one.

Risk scores for predicting early antiretroviral therapy mortality in sub-Saharan Africa to inform who needs intensification of care: a derivation and external validation cohort study

P. Ehrenkranz, S. Charalambous, A. Grant, 2020, BMC Medicine.

Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program.

R. Chaisson, C. Thio, S. Charalambous, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV suppression with stavudine 30 mg versus 40 mg in adults over 60 kg on antiretroviral therapy in South Africa

R. Chaisson, S. Charalambous, A. Grant, 2009, AIDS.

Outcomes of on-site antiretroviral therapy provision in a South African correctional facility

S. Charalambous, A. Grant, G. Churchyard, 2016, International journal of STD & AIDS.

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

A. Diacon, M. Hoelscher, K. Reither, 2017, The Lancet. Infectious diseases.

Resistance to Tenofovir-Based Regimens during Treatment Failure of Subtype C HIV-1 in South Africa

R. Chaisson, L. Morris, S. Charalambous, 2013, Antiviral therapy.

Viral Suppression Following Switch to Second-line Antiretroviral Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor Resistance and Subtherapeutic Drug Concentrations Prior to Switch

A. Phillips, L. Morris, S. Charalambous, 2013, The Journal of infectious diseases.

Isoniazid preventive therapy use among patients on antiretroviral therapy: a missed opportunity.

S. Charalambous, G. Churchyard, T. Kufa, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study

S. Charalambous, A. Grant, G. Churchyard, 2010, AIDS.

Major Neutrophil-Derived Soluble Mediators Associate With Baseline Lung Pathology and Post-Treatment Recovery in Tuberculosis Patients

S. Charalambous, A. Rachow, S. Donkor, 2021, Frontiers in Immunology.

The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions

M. Pai, K. Dheda, J. Peter, 2022, The Lancet Respiratory Medicine.

Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models

Andreas Handel, Mehran Hosseini, Tom Sumner, 2016, The Lancet. Global health.

HIV testing services in healthcare facilities in South Africa: a missed opportunity

B. Hansoti, S. Charalambous, C. Hoffmann, 2019, Journal of the International AIDS Society.

Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis

R. Shorten, A. Crook, A. Diacon, 2018, BMC Medicine.

Contribution of reinfection to recurrent tuberculosis in South African gold miners.

R. Chaisson, R. Hayes, S. Charalambous, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Does tuberculosis increase HIV load?

R. Chaisson, R. Hayes, A. Puren, 2004, The Journal of infectious diseases.

Impact of Drug Resistance-Associated Amino Acid Changes in HIV-1 Subtype C on Susceptibility to Newer Nonnucleoside Reverse Transcriptase Inhibitors

D. Katzenstein, R. Shafer, D. Pillay, 2014, Antimicrobial Agents and Chemotherapy.

Factors influencing uptake of HIV care and treatment among children in South Africa – a qualitative study of caregivers and clinic staff

S. Charalambous, A. Grant, G. Churchyard, 2010, AIDS care.

Evaluation of a workplace HIV treatment programme in South Africa

L. Kumaranayake, S. Charalambous, A. Grant, 2007, AIDS.

Durable HIV RNA resuppression after virologic failure while remaining on a first‐line regimen: a cohort study

R. Chaisson, L. Morris, S. Charalambous, 2014, Tropical medicine & international health : TM & IH.

Second-Line Antiretroviral Therapy in a Workplace and Community-Based Treatment Programme in South Africa: Determinants of Virological Outcome

A. Phillips, S. Charalambous, A. Grant, 2012, PloS one.

Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa

D. Katzenstein, Z. El-Khatib, M. Petzold, 2010, AIDS (London).

Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa.

R. Chaisson, L. Morris, S. Charalambous, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Attitudes to directly observed antiretroviral treatment in a workplace HIV care programme in South Africa

S. Charalambous, A. Grant, G. Churchyard, 2007, Sexually Transmitted Infections.

Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa

James J. Lewis, S. Charalambous, G. Churchyard, 2018, PloS one.

HIV-1 re-suppression on a first-line regimen despite the presence of phenotypic drug resistance

L. Morris, S. Charalambous, C. Hoffmann, 2020, PloS one.

Factors Associated With Poor Linkage to HIV Care in South Africa: Secondary Analysis of Data From the Thol'impilo Trial

S. Charalambous, K. Fielding, J. Dorward, 2017, Journal of acquired immune deficiency syndromes.

Household HIV Testing Uptake among Contacts of TB Patients in South Africa

James J. Lewis, S. Charalambous, G. Churchyard, 2016, PloS one.

Author ' s response to reviews Title : Contrasting predictors of poor adherence to antiretroviral therapy in two South African treatment programmes : a cohort study

S. Charalambous, A. Grant, G. Churchyard, 2010 .

Perceptions of Value and Cost of HIV Care Engagement Following Diagnosis in South Africa

S. Charalambous, C. Hoffmann, C. Kennedy, 2018, AIDS and Behavior.

Tuberculosis among HIV-infected population: incidence and risk factors in rural Tanzania.

F. Lwilla, A. Mkopi, K. Reither, 2017, African health sciences.

Estimating the yield of tuberculosis from key populations to inform targeted interventions in South Africa: a scoping review

S. Charalambous, G. Churchyard, Nishila Moodley, 2020, BMJ Global Health.

An intervention to optimise the delivery of integrated tuberculosis and HIV services at primary care clinics: results of the MERGE cluster randomised trial.

A. Vassall, S. Charalambous, A. Grant, 2018, Contemporary clinical trials.

The incidence of tuberculosis among hiv-positive individuals with high CD4 counts: implications for policy

V. Mngomezulu, S. Charalambous, G. Churchyard, 2016, BMC Infectious Diseases.

Description of adverse events among adult men following voluntary medical male circumcision: Findings from a circumcision programme in two provinces of South Africa

Vincent Muturi-Kioi, S. Charalambous, C. Chetty-Makkan, 2021, PloS one.

Costs of implementing universal test and treat in three correctional facilities in South Africa and Zambia

S. Charalambous, R. Mukora, K. Fielding, 2022, PLoS ONE.

S. Charalambous, K. Fielding, C. Hoffmann, 2021, PLoS ONE.

The case for pre-exposure prophylaxis in prison settings.

S. Charalambous, L. Chimoyi, 2022, The lancet. HIV.

Correction: HIV-related stigma and uptake of antiretroviral treatment among incarcerated individuals living with HIV/AIDS in South African correctional settings: A mixed methods analysis

S. Charalambous, K. Fielding, C. Hoffmann, 2021, PloS one.

Exploring perceptions of low risk behaviour and drivers to test for HIV among South African youth

S. Charalambous, C. Hoffmann, Tshifhiwa Muravha, 2021, PloS one.

A qualitative exploration into the presence of TB stigmatization across three districts in South Africa

S. Charalambous, K. Fielding, R. Lessells, 2023, BMC Public Health.

Factors associated with low tuberculosis preventive therapy prescription rates among health care workers in rural South Africa

S. Charalambous, A. Moll, Megan A Grammatico, 2021, Global health action.

“They are gaining experience; we are gaining extra hands”: a mixed methods study to assess healthcare worker perceptions of a novel strategy to strengthen human resources for HIV in South Africa

Gabrielle E. O'Malley, S. Charalambous, A. Duerr, 2023, BMC Health Services Research.

HIV incidence and predictors of inconsistent condom use among adult men enrolled into an HIV vaccine preparedness study, Rustenburg, South Africa

N. Hills, S. Charalambous, C. Lindan, 2019, PloS one.

Addressing Common Mental Health Disorders Among Incarcerated People Living with HIV: Insights from Implementation Science for Service Integration and Delivery

M. Muyoyeta, J. Kane, S. Charalambous, 2020, Current HIV/AIDS Reports.

Pregnancy Incidence and Correlates in a Clinical Trial Preparedness Study, North West Province South Africa

S. Charalambous, K. Fielding, P. Feldblum, 2014, PloS one.

HIV infection does not affect active case finding of tuberculosis in South African gold miners.

R. Hayes, James J. Lewis, S. Charalambous, 2009, American journal of respiratory and critical care medicine.

Evaluation of antiretroviral therapy (ART)-related counselling in a workplace-based ART implementation programme, South Africa

S. Charalambous, A. Grant, G. Churchyard, 2005, AIDS care.

Preventive Treatment for Household Contacts of Drug-Susceptible Tuberculosis Patients

S. Charalambous, C. Mulder, V. Chihota, 2022, Pathogens.

TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB – a study protocol

S. Niemann, M. Hoelscher, U. Schaible, 2019, BMC Pulmonary Medicine.

Four Models of HIV Counseling and Testing: Utilization and Test Results in South Africa

S. Charalambous, G. Churchyard, C. Hoffmann, 2014, PloS one.

Understanding factors influencing utilization of HIV prevention and treatment services among patients and providers in a heterogeneous setting: A qualitative study from South Africa

S. Charalambous, E. Musenge, J. Chikovore, 2022, PLOS global public health.

Health system determinants of tuberculosis mortality in South Africa: a causal loop model

S. Charalambous, A. von Delft, A. Hesseling, 2021, BMC Health Services Research.

Annual Tuberculosis Preventive Therapy for Persons With HIV Infection

R. Chaisson, F. Cobelens, S. Charalambous, 2021, Annals of Internal Medicine.

Exploring the promise and reality of ward-based primary healthcare outreach teams conducting TB household contact tracing in three districts of South Africa

S. Charalambous, K. Fielding, R. Lessells, 2021, PloS one.

Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trial.

S. Dorman, A. Vassall, S. Charalambous, 2019, The lancet. HIV.

Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study

S. Charalambous, K. Fielding, G. Rankgoane-Pono, 2021, PLoS medicine.

An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19

James J. Lewis, S. Charalambous, G. Churchyard, 2020, PloS one.

Empirical estimation of resource constraints for use in model-based economic evaluation: an example of TB services in South Africa

Richard G. White, A. Vassall, S. Charalambous, 2018, Cost Effectiveness and Resource Allocation.

Strengthening the Mentorship and Leadership Capacity of HIV/AIDS and Tuberculosis Researchers in South Africa.

L. Curry, M. Desai, L. Manderson, 2021, The American journal of tropical medicine and hygiene.

Monitoring Anti-tuberculosis Treatment Response Using Analysis of Whole Blood Mycobacterium tuberculosis Specific T Cell Activation and Functional Markers

H. Dockrell, S. Charalambous, A. Rachow, 2020, Frontiers in Immunology.

Prevalence and risk factors of tuberculosis disease in South African correctional facilities in 2015.

K. Castro, S. Charalambous, L. Podewils, 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Do Incarcerated Populations Serve as a Reservoir for Tuberculosis in South Africa?

S. Charalambous, J. Donahoe, Z. McLaren, 2018, The American journal of tropical medicine and hygiene.

Implementing a Large-Scale Systematic Tuberculosis Screening Program in Correctional Facilities in South Africa

S. Charalambous, G. Churchyard, C. Hoffmann, 2014, Open forum infectious diseases.

Verbal autopsy-assigned causes of death among adults being investigated for TB in South Africa

K. Kahn, S. Charalambous, A. Grant, 2016, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Scaling up evidence-based approaches to tuberculosis screening in prisons.

J. Andrews, F. Altice, M. Muyoyeta, 2023, The Lancet. Public health.

Is HIV Post-test Counselling Aligned with Universal Test and Treat Goals? A Qualitative Analysis of Counselling Session Content and Delivery in South Africa

S. Charalambous, C. Hoffmann, D. Kerrigan, 2020, AIDS and Behavior.

Feasibility of implementing same-day antiretroviral therapy initiation during routine care in Ekurhuleni District, South Africa: Retention and viral load suppression

B. Hansoti, S. Charalambous, C. Hoffmann, 2020, Southern African journal of HIV medicine.

Depression and alcohol use disorder at antiretroviral therapy initiation led to disengagement from care in South Africa

S. Charalambous, C. Hoffmann, C. Cichowitz, 2017, PloS one.

The association between social capital and HIV treatment outcomes in South Africa

S. Charalambous, G. Nelson, Grace Musanse Mukoswa, 2017, PloS one.

Digital adherence technology for TB: focus on livelihoods as well as lives.

S. Charalambous, R. Houben, M. Quaife, 2021, The International Journal of Tuberculosis and Lung Disease.

Strategies to Accelerate HIV Care and Antiretroviral Therapy Initiation After HIV Diagnosis: A Randomized Trial

D. Dowdy, S. Charalambous, G. Churchyard, 2017, Journal of acquired immune deficiency syndromes.

Qualitative study exploring the feasibility of using medication monitors and a differentiated care approach to support adherence among people receiving TB treatment in South Africa

C. Orrell, S. Charalambous, R. Mukora, 2023, BMJ open.

Youth Preferences for HIV Testing in South Africa: Findings from the Youth Action for Health (YA4H) Study Using a Discrete Choice Experiment

S. Charalambous, C. Hoffmann, Hae-Young Kim, 2020, AIDS and Behavior.

Arylacetamide deacetylase (AADAC) gene polymorphism and HIV infection affect the exposure of Rifapentine: a population pharmacokinetics analysis.

S. Dorman, M. Hatherill, P. Denti, 2019 .

“To speak or not to speak”: A qualitative analysis on the attitude and willingness of women to start conversations about voluntary medical male circumcision with their partners in a peri-urban area, South Africa

S. Charalambous, V. Chihota, C. Chetty-Makkan, 2019, PloS one.

Effectiveness of an “Exclusive Intervention Strategy” to increase medical male circumcision uptake among men aged 25–49 years in South Africa

S. Charalambous, C. Chetty-Makkan, J. Grund, 2018, BMC Public Health.

Delivering PrePex Medical Male Circumcision Services Through a Mobile Clinic: The Experience From a Pilot Project in North West Province, South Africa

S. Charalambous, V. Chihota, C. Toledo, 2016, Journal of acquired immune deficiency syndromes.

Data quality assessment of a South African electronic registry for drug-resistant TB, 2015-2016.

S. Charalambous, Y. F. van der Heijden, K. Velen, 2021, Public health action.

HIV prevalence and the cascade of care in five South African correctional facilities

K. Castro, S. Charalambous, L. Podewils, 2020, PloS one.

Small area analysis of HIV viral load suppression patterns in a high priority district (2012–2016), South Africa

S. Charalambous, K. Otwombe, E. Musenge, 2023, PLOS Global Public Health.

The utility of repeat Xpert MTB/RIF testing to diagnose tuberculosis in HIV-positive adults with initial negative result

A. Vassall, M. Nicol, S. Charalambous, 2018, Gates Open Research.

Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models

Richard G. White, Stewart T. Chang, M. Feldman, 2016, The Lancet. Global health.

Does a youth intern programme strengthen HIV service delivery in South Africa? An interrupted time‐series analysis

S. Charalambous, G. Churchyard, A. Duerr, 2023, Journal of the International AIDS Society.

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial

L. Rigouts, T. Heupink, G. Maartens, 2022, Trials.

Lessons learnt conducting minimally invasive autopsies in private mortuaries as part of HIV and tuberculosis research in South Africa.

S. Charalambous, A. Grant, G. Churchyard, 2019, Public health action.

Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol

S. Charalambous, K. Fielding, M. Quaife, 2023, BMJ Open.

Impact of Drug Resistance-Associated Amino Acid Changes in HIV-1 Subtype C on Susceptibility to Newer Nonnucleoside Reverse Transcriptase Inhibitors

D. Katzenstein, R. Shafer, D. Pillay, 2014, Antimicrobial Agents and Chemotherapy.

Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment

J. Andrews, M. Muyoyeta, S. Charalambous, 2023, PLoS medicine.

Diagnostic Accuracy of a Urine Lipoarabinomannan Enzyme-Linked Immunosorbent Assay for Screening Ambulatory HIV-Infected Persons for Tuberculosis

R. Chaisson, S. Dorman, V. Mngomezulu, 2011, Journal of acquired immune deficiency syndromes.

Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.

Richard G. White, Stewart T. Chang, N. Arinaminpathy, 2016, The Lancet. Global health.

Digital chest radiography enhances screening efficiency for pulmonary tuberculosis in primary health clinics, South Africa.

S. Charalambous, G. Churchyard, Nishila Moodley, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparing QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube for diagnosis of latent tuberculosis infection among highly TB exposed gold miners in South Africa [version 3; peer review: 1 approved] the Plus with

T. Hawn, S. Charalambous, A. Grant, 2022 .

Protein binding of rifampicin is not saturated when using high-dose rifampicin

Carlijn H. C. Litjens, A. Diacon, M. Hoelscher, 2018, The Journal of antimicrobial chemotherapy.

Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa

D. Katzenstein, Z. El-Khatib, M. Petzold, 2010, AIDS.

High-dose rifampicin, moxiﬂ oxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

R. Dawson, S. Charalambous, N. Heinrich, 2019 .

How important are human immunodeficiency virus (HIV) clinical markers to the long-term formal employment among people living with HIV in developing countries? A study in South Africa.

S. Charalambous, W. Odek, A. Glendinning, 2014, Work.

Observational study of continuity of HIV care following release from correctional facilities in South Africa

S. Charalambous, C. Hoffmann, Nolundi T. Mshweshwe-Pakela, 2020, BMC Public Health.

Bmc Infectious Diseases Risk Factors for Poor Virological Outcome at 12 Months in a Workplace-based Antiretroviral Therapy Programme in South Africa: a Cohort Study

R. Wood, S. Charalambous, A. Grant, 2022 .